ReviewDrug target insights

The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields.

Iyad Y Natsheh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.